People: Hospira Inc (HSP.N)

HSP.N on New York Stock Exchange

62.44USD
26 Dec 2014
Price Change (% chg)

$-0.16 (-0.26%)
Prev Close
$62.60
Open
$62.83
Day's High
$62.94
Day's Low
$62.33
Volume
80,743
Avg. Vol
211,328
52-wk High
$63.14
52-wk Low
$40.44

Search Stocks

Summary

Name Age Since Current Position

John Staley

72 2012 Independent Non-Executive Chairman of the Board

F. Michael Ball

58 2011 Chief Executive Officer, Director

Thomas Werner

56 2006 Chief Financial Officer, Senior Vice President - Finance

David Endicott

49 2014 President, Hospira Medical Devices

Kenneth Meyers

52 2013 Chief Human Resource Officer, Senior Vice President

Daphne Jones

56 2009 Chief Information Officer, Senior Vice President

Sumant Ramachandra

45 2013 Senior Vice President, Chief Scientific Officer

Richard Davies

52 2012 Senior Vice President, Chief Commercial Officer

John Elliot

62 2013 Senior Vice President - International Pharmaceutical Operations

Zena Kaufman

57 2012 Senior Vice President - Quality

Brian Smith

62 2013 Senior Vice President, Chief Legal Officer

Matthew Stober

46 2013 Senior Vice President - Operations

Richard Hoffman

47 2009 Chief Accounting Officer, Corporate Vice President, Controller

Royce Bedward

2013 Corporate Vice President, General Counsel, Secretary

Marc Yoskowitz

2013 Corporate Vice President - Strategy and Corporate Development

Irving Bailey

73 2011 Independent Director

Barbara Bowles

66 2008 Independent Director

William Dempsey

62 2011 Independent Director

Dennis Fenton

62 2012 Independent Director

Roger Hale

70 2006 Independent Director

Jacque Sokolov

59 2004 Independent Director

Heino Von Prondzynski

65 2009 Independent Director

Mark Wheeler

64 2006 Independent Director

Karen King

Corporate Vice President - Investor Relations

Biographies

Name Description

John Staley

Mr. John C. Staley is an Independent Non-Executive Chairman of the Board of Hospira, Inc. Mr. Staley has been a Hospira director since the company’s inception in 2004. Mr. Staley served as the Managing Partner of the Lake Michigan Area of Ernst & Young LLP, a public accounting firm, a position that he held from 1985 to his retirement in June 2001. In addition, Mr. Staley serves as a director of Mattersight Corporation. Mr. Staley is also a member of, and the former Chairman of, the Board of Trustees of DePaul University. Within the past five years, Mr. Staley has also served as a director of Centerpoint Corporation (from 2002 to 2006) and Nicor Inc. (from 2008 to 2011).

F. Michael Ball

Mr. F. Michael Ball is Chief Executive Officer, Director of Hospira, Inc. Mr. Ball joined Hospira after a 16-year career at Allergan, Inc., a multi-specialty healthcare company, where he held several senior leadership positions. More recently, from February 2006 until joining Hospira, Mr. Ball served as President of Allergan. From October 2003 to February 2006, Mr. Ball served as Executive Vice President and President, Pharmaceuticals of Allergan. Since 2013, Mr. Ball serves on the board of Kythera Biopharmaceutical, Inc., a publicly traded clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. Mr. Ball also served on the board of directors of STEC, Inc., a publicly traded manufacturer and marketer of computer memory and hard drive storage solutions, from 2000 to 2013.

Thomas Werner

Mr. Thomas E. Werner is Chief Financial Officer, Senior Vice President - Finance of Hospira, Inc. He has served in such position since August 2006. Prior to joining Hospira, Mr. Werner served as Senior Vice President, Finance and Chief Financial Officer of Böwe Bell + Howell, a service, manufacturing and software company that provides document processing and postal solutions.

David Endicott

Mr. David J. Endicott has been appointed as President, Hospira Medical Devices of Hospira, Inc., effective March 10, 2014. Mr. Endicott, most recently served as President, Allergan Medical, Asia Pacific and Latin America and as an executive committee member of Allergan, Inc., a global specialty drug and medical device company. Prior to this position, he served as President, Europe, Africa and Middle East. During his tenure at Allergan, he held roles of progressive responsibility across a variety of functions, driving rapid growth in global markets, developing deep operating experience and demonstrating great success in building integrated, high-performing teams. Mr. Endicott earned his bachelor's degree in chemistry from Whitman College, his master's in business administration from the University of Southern California and is a graduate of the Harvard Business School Advanced Management Program.

Kenneth Meyers

Mr. Kenneth F. Meyers is Chief Human Resource Officer, Senior Vice President of Hospira, Inc. Mr. Meyers has served in that position for the past five years.

Daphne Jones

Ms. Daphne E. Jones is Chief Information Officer, Senior Vice President of Hospira, Inc. Ms. Jones has served in that position since November 2009. Ms. Jones served as the Worldwide Vice President of Information Technology and Chief Information Officer for Johnson & Johnson's Ortho-Clinical Diagnostics, Inc. (a Johnson & Johnson company that provides solutions for screening, diagnosing, monitoring and confirming diseases early) in 2009.

Sumant Ramachandra

Dr. Sumant Ramachandra M.D., Ph.D., is Senior Vice President, Chief Scientific Officer of Hospira, Inc. Dr. Ramachandra has served in that position from May 2013 to the present and from July 2008 to March 2013. For the period March 2013 to May 2013, Dr. Ramachandra served as the President, R&D of Synta Pharmaceuticals Corporation, a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs. Dr. Ramachandra then pursued a combined M.D./Ph.D. degree from the University of Medicine and Dentistry-New Jersey Medical School, receiving the University's Medal of Excellence and subsequently conducting his residency at the Harvard-affiliated Massachusetts General Hospital. He also earned a master's of business administration at Wharton Business School.

Richard Davies

Mr. Richard John Davies is Senior Vice President, Chief Commercial Officer of Hospira, Inc. He has served in that position since February 2012. From August 2011 to February 2012, Mr. Davies served as Vice President and General Manager, Japan and Asia Pacific at Amgen, Inc. (a developer and manufacturer of human therapeutics). From 2010 to August 2011, Mr. Davies was Vice President and General Manager, Asia and Latin America, and from 2009 through 2010, he served as Vice President, Sales Inflammation Business Unit.

John Elliot

Mr. John B. Elliot is Senior Vice President - International Pharmaceutical Operations of Hospira, Inc. He has served in that position since April 2013. From April 2012 to April 2013, Mr. Elliot served as Hospira’s Senior Vice President, Operations. From 2010 to 2012, Mr. Elliot served as a consultant with Pharma Associates, Ltd. (a management consulting business). Throughout 2009 and up to 2010, he served as the President of Cherokee Pharmaceuticals, LLC (a wholly owned subsidiary of PRWT Services, Inc., and a U.S.-based active pharmaceutical ingredient manufacturing company) and from 2008 through 2010, was also Chairman. From 2008 through 2010, Mr. Elliot served as a Director of Print, Inc.

Zena Kaufman

Ms. Zena G. Kaufman is Senior Vice President - Quality of Hospira, Inc. Ms. Kaufman has served in that position since February 2012. Prior to joining Hospira, Ms. Kaufman served as Divisional Vice President ("DVP"), Global Quality Systems, Global Pharmaceutical Operations at Abbott Laboratories (a global broad-based provider of healthcare products) from 2011 to 2012. Ms. Kaufman also held the following positions at Abbott Laboratories: DVP, Global Pharmaceutical Operations, Small Molecule Quality Assurance (January 2011 to September 2011); DVP, Global Pharmaceutical Operations (March 2009 to January 2011); DVP, Corporate Quality and Regulatory, Quality Center of Excellence (up to March 2009).

Brian Smith

Mr. Brian J. Smith is Senior Vice President and Chief Legal Officer of Hospira, Inc. He has served in that position since February 2013. From 2004 until February 2013, Mr. Smith was Hospira’s Senior Vice President, General Counsel; and from 2004 to February 2012, also served as Secretary. Smith earned a bachelor's degree in political science at Bradley University in 1973, and a juris doctorate from the University of Michigan in 1976. He is a member of the Illinois and American Bar Associations.

Matthew Stober

Mr. Matthew R. Stober is Senior Vice President - Operations of Hospira, Inc. He previously served as Hospira’s Corporate Vice President, U.S. Pharmaceutical Operations from December 2011 to April 2013. Prior to joining Hospira, from June 2011 to December 2011, Mr. Stober served as Vice President and Global Platform Leader for Solids, Parenterals and Vaccines at Johnson & Johnson (a multi-national manufacturer of pharmaceutical, diagnostic, surgical, personal hygiene and biotechnology products). In 2009 to 2011, Mr. Stober served as the Global Head of Technical Operations, Vaccines and Diagnostics at Novartis AG (a multi-national manufacturer of pharmaceuticals, vaccines, consumer health, generics, eye care and animal health).

Richard Hoffman

Mr. Richard J. Hoffman is Chief Accounting Officer, Corporate Vice President, Controller of Hospira, Inc. He has served in such position since August 2009. From August 2007 to August 2009, he served as Hospira's Vice President, Corporate Controller and Chief Accounting Officer. From 2000 until his appointment by Hospira, Mr. Hoffman was employed by CNH Global N.V. (Case New Holland—a global agricultural and construction equipment manufacturer with a captive financial services company). His last position was Vice President, Corporate Controller and Chief Accounting Officer, which he held since July 2004. Prior to that time, he served as Assistant Corporate Controller and Chief Accounting Officer and in various other finance and reporting roles at Case New Holland.

Royce Bedward

Mr. Royce R. Bedward is Corporate Vice President, General Counsel and Secretary of Hospira, Inc. In this role he is responsible for the company's legal department, including litigation, benefits, labor and employment, intellectual property, governance, securities and transactional matters. One of the founding members of Hospira's legal leadership team, Bedward joined the company at its inception in 2004 as vice president of litigation, assuming roles of increasing responsibility, most recently holding the position of deputy general counsel and secretary. Prior to the company's spin-off from Abbott Laboratories, Bedward served as Abbott's senior counsel, litigation, where his practice included patent issues related to the Hatch-Waxman Act, defense of investigations, major commercial disputes, product liability matters and arbitrations. Bedward joined Abbott Laboratories in 2002. Bedward began his career as an attorney for the law firm Jenner & Block, where he was ultimately promoted to partner. At the firm, he handled a wide array of complex litigation matters, including fraud and business torts, intellectual property matters, product liability and insurance recovery actions. Bedward received his bachelor's degree in business administration from St. Norbert College and a juris doctorate from the University of Illinois College of Law.

Marc Yoskowitz

Irving Bailey

Mr. Irving W. Bailey, II, is an Independent Director of Hospira, Inc. He served as the lead director from 2007 to 2011. Mr. Bailey served as a Managing Director of Chrysalis Ventures, a private equity management firm, from June 2001 to January 2005, and has served as a Senior Advisor to Chrysalis Ventures, since January 2005. Mr. Bailey served as President of Bailey Capital Corporation, a private equity management firm, from January 1998 to June 2001, and as Chief Executive Officer of Providian Corporation, an insurance and diversified financial services company, from 1988 to 1997. Mr. Bailey also serves as Vice Chairman of Aegon, N.V. and was a director of Computer Sciences Corporation, until August 2013. He also serves as an officer and a director on the following nonprofit boards: The Beauregard Foundation, Inc. and Operation Open Arms, Inc.

Barbara Bowles

Ms. Barbara L. Bowles, is an Independent Director of Hospira, Inc. She founded and serves as president of the Landers Bowles Family Foundation, which is dedicated to providing charitable gifts primarily to educational entities in order to support disadvantaged high school and college students. She served as the Vice Chair of Profit Investment Management, an equity investment advisory firm, from January 2006 until retiring in December 2007. She was the founder and served as Chairman (2000 to 2006) and Chief Executive Officer (1989 to 2005) of the Kenwood Group, Inc., an equity investment firm until it was acquired by Profit Investment Management. From 1984 to 1989, Ms. Bowles was Corporate Vice President and Director, Investor Relations, for Kraft, Inc., a diversified packaged food and beverage company. Ms. Bowles serves as a director of Wisconsin Energy Corporation, the Chicago Urban League, and the Museum of Science and Industry, Chicago. She is a trustee and chair of Fisk University and also serves on the University of Chicago Booth School of Business Advisory Council. Within the past five years, Ms. Bowles has served as a director of Black & Decker Corporation (from 1993 to 2010). She also has served as a director of Lurie Children's Hospital (from 1991 through November of 2011); and, after retiring as a regular member, became an honorary senior member.

William Dempsey

Mr. William G. Dempsey is an Independent Director of Hospira, Inc. Mr. Dempsey provided 25 years of service to Abbott Laboratories ("Abbott") (a global broad-based healthcare company), and in his last position at Abbott, from 2006 until his retirement in 2007, served as Executive Vice President, Global Pharmaceuticals. From 2003 to 2006, Mr. Dempsey served at Abbott as its Senior Vice President, Pharmaceutical Operations. From 1982 to 2003, Mr. Dempsey held several other senior management positions at Abbott. Mr. Dempsey currently serves on the board of Landauer Inc., Nordion Inc., and in March 2014, was elected to serve on the board of Hill-Rom, Inc. He also serves as a trustee on the Guadalupe Center Board of Trustees, and recently resigned as Chair of the Scientific Evaluation Committee for the MPN Foundation.

Dennis Fenton

Dr. Dennis M. Fenton, Ph.D., is an Independent Director of Hospira, Inc. Dr. Fenton is the owner and CEO of Fenton and Associates (biotechnology consulting). Prior to that, for over 25 years, Dr. Fenton held numerous positions, including executive roles in process development, manufacturing, sales and marketing, and research and development at Amgen, Inc., a biotechnology company. Most recently, from 2000 to 2008, he served as the Executive Vice President, Operations at Amgen. Dr. Fenton currently serves on the board of Dendreon Corporation, Kythera Biopharmaceuticals, Inc., and Xenoport, Inc. Within the past five years, Dr. Fenton also has served as a director of Genzyme Corporation (from 2010 to 2011), was chair of the Scientific Advisory Board (from 2010 to 2013), and acted as a board observer for Althea Technologies in 2013. He also serves on the nonprofit boards of Scripps Research Institute, and Keck Graduate Institute.

Roger Hale

Mr. Roger W. Hale is an Independent Director of Hospira, Inc. He has served as Chairman of the Board and Chief Executive Officer of LG&E Energy Corporation, a diversified energy services company, from August 1990 until retiring in April 2001. Prior to joining LG&E Energy Corporation, he was Executive Vice President of BellSouth Corporation, a communications services company. From 1966 to 1986, Mr. Hale held several executive positions with AT&T Co., a communications services company, including Vice President, Southern Region from 1983 to 1986. Mr. Hale is also a director of Ashland, Inc. Within the past five years, Mr. Hale also has served as a director of H&R Block, Inc. (from 1991 to 2008).

Jacque Sokolov

Dr. Jacque J. Sokolov, M.D., is an Independent Director of Hospira, Inc. Dr. Sokolov has served since 1997 as the Chairman and Managing Partner of SSB Solutions, Inc., a national healthcare management consulting, project development and investment firm. From 1987 to 1992, Dr. Sokolov served as the Vice President of Healthcare for Southern California Edison. In 1992, Dr. Sokolov became CEO of Advanced Health Plans Inc., which was acquired in 1994 by Coastal Physicians Group Inc. From 1994 to 1997, Dr. Sokolov served as Chairman of the Board, Chairman of the Executive Committee, and Chairman of the Management Action Committee of Coastal Physician Group, Inc., which for the National Health Foundation, Phoenix Children's Hospital, and the White House Health Project.

Heino Von Prondzynski

Mr. Heino von Prondzynski is an Independent Director of Hospira, Inc. Mr. v. Prondzynski served as chief executive officer of Roche Diagnostics and as a member of the executive committee of F. Hoffman-La Roche Ltd., a Swiss-based healthcare company that develops diagnostic and therapeutic products, from early 2000 to 2005, retiring from Roche at the end of 2006. From 1996 to 2000, Mr. v. Prondzynski held several executive positions at Chiron Corporation, a multinational biotechnology firm that develops biopharmaceuticals, vaccines, and blood testing products, and from 1976 to 1996 at Bayer AG, a German-based maker of healthcare products, specialty materials, and agricultural products. Mr. v. Prondzynski also serves on the board of Qiagen NV and Koninklijke Philips Electronics NV. Within the past five years, Mr. v. Prondzynski also has served as a director of Epigenomics AG (from 2007 to 2010) and Nobel Biocare Holding AG, Switzerland (from 2010 to 2011).

Mark Wheeler

Dr. Mark F. Wheeler, M.D., is an Independent Director of Hospira, Inc. Since September 2010, From September 2010 until June 2012, when he retired, Dr. Wheeler served as the System Vice President, CIO and CMIO for PeaceHealth, an integrated delivery network of hospitals in the Pacific Northwest. From January 2007 to September 2010, he served as the Director of Clinical Informatics for PeaceHealth. He previously served as Acting Vice President Engineering, Centricity Enterprise Business Unit of General Electric Company, a diversified technology, media and financial services company, from February 2006 to January 2007. He served as chief technical architect of IDX Systems Corporation ("IDX"), a healthcare information technology services provider, from 1997 until December 2005, when IDX was acquired by General Electric, and served on IDX's board of directors from 1999 through 2005. He also serves on the nonprofit board of Washington Wine Industry Foundation.

Karen King

Search Stocks